Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Anesthesia
Description:
Welcome to today’s episode, where we explore the latest advances in anesthesia. In recent years, anesthesia has become safer and more precise, thanks to innovations like target-controlled infusions and advanced monitoring systems. These tools allow doctors to deliver exact doses and adjust anesthesia in real time, reducing risks and speeding up recovery. New drugs with fewer side effects are making procedures even safer for patients of all ages. Additionally, artificial intelligence is helping anesthesiologists predict complications before they happen. These advances not only improve patient safety but also enhance comfort during surgeries. Stay tuned as we continue to bring you the latest updates from the world of medical science.
See More Webinars @ Hidoc Webinars
1.
In 18 States, alcohol exclusion laws are still in effect.
2.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
3.
Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer
4.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
5.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
1.
Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide
2.
Risk Assessment of Cancer-Associated Thrombotic Events
3.
Preventing Developmental Iron Depletion in Childhood
4.
Risk Assessment of Cancer-Associated Endocrine Disorders
5.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
5.
Understanding Blood Clotting Disorders
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge